| mRNA | messenger ribonucleic acid |
| WHO | World Health Organization |
| DNA | deoxyribonucleic acid |
| FDA | Food and Drug Administration |
| DC | dendritic cell |
| TALENs | transcription activator-like effector nucleases |
| EP | electroporation |
| saRNA | self-amplifying mRNA |
| UTR | untranslated region |
| ORF | open reading frame |
| Poly (A) | polyadenylic acid |
| nsPs | nonstructural proteins |
| IVT mRNA | in vitro transcribed mRNA |
| TAA | tumor-associated antigen |
| TSA | tumor-specific antigen |
| APC | antigen-presenting cell |
| PAMPs | pathogen-associated molecular patterns |
| PRRs | pattern recognition receptors |
| TLRs | Toll-like receptors |
| RIG-I | retinoic acid-inducible gene-I |
| RLRs | retinoic acid-inducible gene-I-like receptors |
| hnRNPs | nuclear heterogeneous ribonucleoprotein |
| ZBP1 | Z-DNA-binding protein 1 |
| Th | helper T Cell |
| MHC | major histocompatibility complex |
| CTLs | cytotoxic T lymphocytes |
| CD | cluster of differentiation |
| AKP | alkaline phosphatase |
| eIF4E | eukaryotic initiation factor 4E |
| eIF4G | eukaryotic initiation factor 4G |
| PKR | double-stranded RNA-dependent protein kinase |
| Ψ | pseudouridine |
| m5C | 5-methyl cytosine |
| m6A | 6-methyl adenosine |
| m5U | 5-methyl uracil |
| s2U | 2-thiouracil |
| PABP | poly(A)-binding protein |
| LNPs | lipid nanoparticles |
| PEG | polyethylene glycol |
| DOPE | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine |
| DSPC | 1,2-distearoyl-sn-glycero-3-phosphocholine |
| NHPs | nonhuman primates |
| PEI | polyethyleneimine |
| CP 2k | cationic cyclodextrin-PEI 2k conjugate |
| PAMAM | polyamide amine |
| PLGA | poly (lactic-co-glycolic acid) |
| GFP | green fluorescent protein |
| RNase | ribonuclease |
| LPNs | lipid-polymer hybrid nanoparticles |
| LLPs | lipid-like nanoparticles |
| DOTAP | 1,2-dioleoyl-3-trimethylammonium-propane |
| iPSCs | induced pluripotent stem cells |
| CPPs | cell-penetrating peptides |
| WNT | wingless integrated |
| SD | spray drying |
| SFD | spray freeze drying |
| SEND | selective endogenous encapsidation |
| AuNP | gold nanoparticle |
| i.v. | intravenous injection |
| i.m. | intramuscular injection |
| i.h. | hypodermic injection |
| i.d. | intradermal injection |
| i.p. | intraperitoneal injection |
| i.t. | intratumoral injection |
| i.n. | nasal administration |
| eGFP | enhanced green fluorescent protein |
| Luc | luciferase |
| Fluc | firefly luciferase |
| hGLuc | humanized Gaussia luciferase |
| GM-CSF | granulocyte-macrophage colony-stimulating factor |
| IL-4 | interleukin-4 |
| DI-TMZ | dose-intensified temozolomide |
| CR | complete response |
| HCV | hepatitis C virus |
| HCC | hepatitis C cancer |
| GBM | glioblastoma multiforme |
| PD-1 | programmed cell death protein 1 |
| CTLA-4 | cytotoxic T-lymphocyte-associated protein 4 |
| NSCLC | non-small-cell lung cancer |
| HPV | human papillomavirus |
| PDL-1 | programmed cell death ligand-1 |